Production of the alpha particle emitting radionuclide At-211 at the Texas A&M Cyclotron Institute

被引：0
|
作者：
Bhakta, Vihar [1 ]
Tribble, Robert [2 ]
Alharbi, Abeer [2 ]
Tabacaru, Gabriel [2 ]
Lenox, Mark [3 ]
Akabani, Gamal [1 ]
机构：
[1] Texas A&M Univ, Dept Nucl Engn, College Stn, TX 77843 USA
[2] Texas A&M Univ, Texas A&M Cyclotron Inst, College Stn, TX USA
[3] Texas A&M Univ, Texas A&M Inst Preclin Studies, College Stn, TX USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2011年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1431
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Dr. BA Stewart: Creator and director of the Dryland Agriculture Institute at West Texas A&M University
    Blaser, Brock C.
    AGRONOMY JOURNAL, 2020, 112 (05) : 3278 - 3283
  • [42] Rare isotope production in the Fermi energy regime and application to the Texas A&M RIB Upgrade
    Souiotis, G. A.
    Keksis, A. L.
    Stein, B. C.
    Veselsky, M.
    Jandel, M.
    Shetty, D. V.
    Soisson, S. N.
    Wuenschel, S.
    Yennello, S. J.
    NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS, 2007, 261 (1-2): : 1094 - 1097
  • [43] Astatine-211 labeled Herceptin: An alpha-particle emitting radiotherapeutic.
    Boskovitz, A
    Akabani, G
    Zhao, XG
    Alston, K
    Zalutsky, MR
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6189S - 6189S
  • [44] THE DEVELOPMENT OF A [AT-211]-ASTATINATED ENDORADIOTHERAPEUTIC DRUG .1. LOCALIZATION BY ALPHA-PARTICLE AUTORADIOGRAPHY IN A MURINE TUMOR-MODEL
    BROWN, I
    CARPENTER, RN
    MITCHELL, JS
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1992, 23 (03): : 563 - 572
  • [45] Development of alpha particle emitting radionuclide therapy according to GMP guidelines for treatment of mCRPC
    Hooijman, Eline
    Chalashkan, Yozlem
    Ling, Sui
    Kahyargil, Figen
    Bruchertseifer, Frank
    Morgenstern, Alfred
    Seimbille, Yann
    Koolen, Stijn
    Brabander, Tessa
    de Blois, Erik
    NUCLEAR MEDICINE AND BIOLOGY, 2021, 96-97 : S22 - S23
  • [46] ALPHA-PARTICLE RADIOTHERAPY WITH AT-211-LABELED MONODISPERSE POLYMER PARTICLES, AT-LABELED IGG PROTEINS, AND FREE AT-211 IN A MURINE INTRAPERITONEAL TUMOR-MODEL
    LARSEN, RH
    HOFF, P
    VERGOTE, IB
    BRULAND, OS
    AAS, M
    DEVOS, L
    NUSTAD, K
    GYNECOLOGIC ONCOLOGY, 1995, 57 (01) : 9 - 15
  • [47] Development of meta-[211At]astatobenzylguanidine ([211At]MABG) as an alpha particle emitting systemic targeted radiotherapeutic for neuroblastoma
    Batra, Vandana
    Ranieri, Pietro
    Makvandi, Mehran
    Tsang, Matthew
    Hou, Catherine
    Li, Yimei
    Vaidyanathan, Ganesan
    Pryma, Daniel A.
    Maris, John M.
    CANCER RESEARCH, 2015, 75
  • [48] A new internal target system for production of 211At on the cyclotron U-120M
    Lebeda, O
    Jiran, R
    Rális, J
    Stursa, J
    APPLIED RADIATION AND ISOTOPES, 2005, 63 (01) : 49 - 53
  • [49] High-level production of α-particle-emitting 211At and preparation of 211At-Labeled antibodies for clinical use
    Zalutsky, MR
    Zhao, XG
    Alston, KL
    Bigner, D
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (10) : 1508 - 1515
  • [50] Cellular S-factors for alpha particle emitting radionuclides of interest in radionuclide therapy.
    Sgouros, G
    Hamacher, KA
    Den, RB
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 40P - 40P
12345